Metabolic-based machine learning can be used to build a quantitative risk score for CAD that is associated with atherosclerotic burden, CAD sequelae and mortality
🔗@IainSForrest @OmegaPetrazzini @DoGenetics  @DrDanielJordan @society_eas @ELS_Cardiology